It is well known that tumour-associated macrophages (TAMs) play an important role in tumour development by modulating the tumour microenvironment, and targeting of protumour activation or the M2 polarization of TAMs is expected to be an effective
therapy for
cancer patients. We previously demonstrated that
onionin A (ONA), a natural low molecular weight compound isolated from onions, has an inhibitory effect on M2 macrophage polarization. In the present study, we investigated whether ONA had a therapeutic anti-
ovarian cancer effect using in vitro and in vivo studies. We found that ONA reduced the extent of
ovarian cancer cell proliferation induced by co-culture with human macrophages. In addition, we also found that ONA directly suppressed
cancer cell proliferation. A combinatorial effect with ONA and anti-
cancer drugs was also observed. The activation of
signal transducer and activator of transcription 3 (STAT3), which is involved in cell proliferation and chemo-resistance, was significantly abrogated by ONA in
ovarian cancer cells. Furthermore, the administration of ONA suppressed
cancer progression and prolonged the survival time in a murine
ovarian cancer model under single and combined treatment conditions. Thus, ONA is considered useful for the additional treatment of patients with
ovarian cancer owing to its suppression of the protumour activation of TAMs and direct cytotoxicity against
cancer cells.